Toxicology, ADME & Early Drug Development Plan

Days
Hours
Minutes
Seconds

Toxicology, ADME & Early Drug Development Plan

online live

Training features

Fully online

All sessions of this unique course online

Live interaction

Live interaction options between the delegates and trainer

On any device

Available via mobile, tablet or laptop

meet the training leaders
Dr. Gerhard Hager
CEO
The NCD Company, Germany
Dr. Paolo Rossato
Associate Director, PK & QSP Unit, Pharmacology & Toxicology Department, Research
CSL Behring, Germany
Louise Mawer
GXP Auditor and Trainer
Mirabilitas Ltd, UK
training

Brochure

Reveal the full schedule of the training as well as key topics, course objectives, key takeaways, special features, and the trainer bio!

Toxicology, ADME and Early Drug Development Plan online live training Fleming Agenda cover
Toxicology, ADME and Early Drug Development Plan online live training Fleming Agenda cover
key training

Topics

Absorption, Distribution, Metabolism and Excretion (ADME) and Toxicology studies from Lead Optimization to application for First in Man (FIM) clinical trials

Synergies between ADME and Toxicology studies during early drug development

First human dose prediction

Quality standards during Early Drug Development

Early Drug Development Plan – studies and critical milestones

Key regulatory documents & submission of ADME and Toxicology data

Benefits of attending

Registration

Training ticket

Online Live Stream
FROM
1396

Contact us

DOWNLOAD THE BROCHURE AND REVEAL THE FULL PROGRAM DETAILS

Name
Job
Company
Bio
Name
Description